Skip to content
You are here
Dry Eye Disease Topical Options
Dry Eye Disease Topical Options [Explained]
Feel free to use our complete database with charts, tables and examples.
Medical Treatment of Dry Eye Disease
Exploring the various topical ophthalmic options
According to the American Academy of Ophthalmology no single test is adequate for establishing the diagnosis of dry eye disease.
Dry eye syndrome is one of the most common issues affecting the general population and can be caused by several possible conditions either separately or combined.
With treatment, symptoms often improve, however, the disease usually is not curable.
Dry eye can lead to reduced visual function.
Common symptoms include the following: burning, stinging or itching sensation. Foreign-body sensation. Frequent blinking. Redness. Blurry vision. Light-sensitivity. Eye pain.
Using this program
The program will provide a list of medications for a particular group, common side effects, and other comments that help with selection of a particular product.
Select any option for additional info
Select one or more of the following OTC options:
Options available by prescription:
Select one or more for additional information.
RESTASIS® (cyclosporine) ophthalmic emulsion 0.05%
Xiidra (lifitegrast 5%)
LACRISERT® (hydroxypropyl cellulose) Ophthalmic Insert
American Academy of Ophthalmology Basic and Clinical Science Course Subcommittee. Basic and Clinical Science Course. External Disease and Cornea: Section 8, 2017-2018. San Francisco, CA: American Academy of Ophthalmology; 2017:55-56.
Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21(4):221-232.80.
Fox RI. Systemic diseases associated with dry eye. Int Ophthalmol Clin. 1994;34(1):71-87.
The Dry Eye Assessment and Management Study Research Group. n−3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. N Engl J Med 2018; 378:1681-1690 DOI: 10.1056/NEJMoa1709691
Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45(suppl 2): S211–S220.
Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151:792– 798.e1.
Wang MTM, Tien L, Han A, et al. Impact of blinking on ocular surface and tear film parameters. Ocul Surf. 2018.
Mathews PM, Karakus S, Agrawal D, Hindman HB, Ramulu PY, Akpek EK. Tear osmolarity and correlation with ocular surface parameters in patients with dry eye. Cornea. 2017;36(11):1352-1357.
Holland EJ, Luchs J, Karpecki PM, et al. Lifitegrast for the treatment of dry eye disease: results of a phase III, randomized, double-masked, placebo-controlled trial (OPUS-3). Ophthalmology. 2017;124(1):53-60.
Mathews PM, Ramulu PY, Swenor BS, Utine CA, Rubin GS, Akpek EK. Functional impairment of reading in patients with dry eye. Br J Ophthalmol. 2017;101(4):481-486.
Ophthalmology Related Tables and Apps
Ophthalmic Antibacterials and combination products
Ophthalmic Anti-allergy agents
Ophthalmic - Dry eye disease (DED)
Ophthalmic - Glaucoma
Carbonic anhydrase inhibitors
Rho kinase (ROCK) inhibitors
Fixed Combination Medications
Benzalkonium chloride (BAK)-Free products
Comparative effectiveness of glaucoma drops
New Glaucoma Drug Selection tool - Medical App
Potency of Glaucoma drops - Medical App
Glaucoma - BAK-free and Preservative-free drops Medical App
Medical Treatment of Dry Eye Disease (Ophthalmic drops)- Medical App
Fortified Ophthalmic Preparations
Tool for Evaluating RWE in the Treatment of Retinal Disease
The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure
Diagnosis And Management of Nocardia Keratitis
Retinal Nerve Fiber Layer Thickness In Alzheimer’s Disease
Case Study- Can Giant Cell Arteritis and Myeloproliferative Neoplasm Cause Sudden Onset Vision Loss?
Analysis of The Study on Adverse Reactions to 1% Cyclopentolate Eye Drop in Children
Use of nanotechnology to deliver topical ophthalmic medications
STUDY RESULTS: USE OF ATROPINE TO CONTROL PROGRESSION OF MYOPIA
Study results: Underutilization of generics by U.S. Ophthalmologists
Study Results: ophthalmologic problems amongst patients with Parkinson’s disease